Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuma Tokunaga

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Surgery Today|June 4, 2015
Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patientsKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Oncogene|May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targetsAlberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Cancer Medicine|August 28, 2015
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsMartin D Berger, Yan Ning, Sebastian Stintzing, et al.
Medical Oncology (Northwood, London, England)|February 17, 2016
APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinomaKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
International Journal of Cancer|March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Surgery Today|June 4, 2015
Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patientsKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Oncogene|May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targetsAlberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Cancer Medicine|August 28, 2015
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsMartin D Berger, Yan Ning, Sebastian Stintzing, et al.
Medical Oncology (Northwood, London, England)|February 17, 2016
APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinomaKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
International Journal of Cancer|March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Pageof 8